HRS-7172

· Jiangsu HengRui Medicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HRS-7172, covering 2025-11-17 to 2025-11-17. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of HRS-7172 in Participants With Advanced Solid Tumors Harboring RAS Mutations or Amplifications [Phase 1]

See pricing